Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel Occlusion
Starting soon
Conditions studied: Acute Ischemic Stroke, Large Vessel Occlusion
In brief
The goal of this observational study is to describe the local change in interleukin-6 (IL-6) across a blood clot in adults with acute ischemic stroke caused by anterior circulation large vessel occlusion who are undergoing mechanical thrombectomy. The main questions it aims to answer are: * Is the level of IL-6 different in arterial blood collected beyond the clot compared with arterial blood collected before the clot during mechanical thrombectomy? * Is the trans-thrombus IL-6 difference associated with functional independence 90 days after stroke and with complications related to reperfusion injury? There is no comparison group and no experimental treatment. Researchers will compare paired blood samples collected from opposite sides of the clot in the same participant. Blood collected from a peripheral vein at hospital admission will be used only as a supportive reference for systemic inflammation. Participants will: * Receive standard mechanical thrombectomy and stroke care determined by their treating clinical team. * Have small blood samples collected at planned time points, including paired arterial blood samples collected during the thrombectomy procedure. * Have clinical and imaging information collected from their medical records and have functional status assessed 90 days after stroke. The study will not delay or change standard stroke treatment.
Key facts
- Study ID
- NCT07754942
- Run by
- Zhongshan Hospital Xiamen University
- People needed
- 50
- Starts
- 2026-08-01
- Expected to finish
- 2029-08-01
- Last updated by the study team
- 2026-08-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years or older.
- Acute ischemic stroke caused by anterior circulation large vessel occlusion, confirmed by routine vascular imaging or digital subtraction angiography.
- Undergoing clinically indicated mechanical thrombectomy according to routine clinical practice.
- Provision of written informed consent by the participant or legally authorized representative, in accordance with local ethics requirements.
You may not qualify if…
- Posterior circulation large vessel occlusion.
- Mechanical thrombectomy not performed.
- Known active systemic infection, active malignancy, or chronic inflammatory/autoimmune disease requiring systemic immunosuppressive treatment, when these conditions are expected to substantially affect inflammatory biomarker measurements.
- Pregnancy or breastfeeding, if required by the local ethics committee.
- Enrollment in another interventional study that could affect inflammatory biomarker measurements or clinical outcome assessment.
- Inability to obtain informed consent, where consent from a legally authorized representative is not permitted or cannot be obtained.
Where it is running
- Zhongshan Hospital Xiamen University — Xiamen, Fujian, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.